Updated Patient Resource for Malignant Pleural Mesothelioma Now Available on NCCN.org/patients
By Lacey Marlow, Associate Medical Writer, NCCN
The NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma, Version 1.2014, is now available on NCCN.org/patients. This NCCN Guidelines for Patients® is a high-quality resource for patients and caregivers in the process of planning or receiving treatment. It includes the most recent test and treatment recommendations for each stage of Malignant Pleural Mesothelioma.
This update includes important changes to recommended tests for staging/treatment planning and pre-surgical evaluation. Recommendations for adjuvant treatment and radiation treatment planning have also been expanded and clarified.
The National Comprehensive Cancer Network® (NCCN®) aims to provide people with cancer and the general public with state-of-the-art cancer treatment information in easy-to-understand language. The NCCN Guidelines for Patients, translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are meant to help patients with cancer talk to their doctors about the best treatment options for the type of cancer they have.
NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma was developed according to plain language principles to improve health literacy. The design and format feature patient-friendly elements such as medical illustrations alongside descriptions of body parts, tests, and treatments. It also includes an expansive glossary with definitions of medical terms and acronyms.
NCCN currently offers NCCN Guidelines for Patients for the following: Breast, Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers, Chronic Myelogenous Leukemia, Lung Cancer Screening, Malignant Pleural Mesothelioma, Melanoma, Multiple Myeloma, and Caring for Adolescents and Young Adults (AYA).
Funding for the NCCN Guidelines for Patients is made possible through the NCCN Foundation®.